2025-11-28
The policy explains that variable terms and distribution details may be omitted from the base shelf prospectus and must instead be included in shelf prospectus supplements. It establishes distinct pre-clearance requirements for novel products while allowing non-novel derivatives to bypass regulatory review. Finally, the statement defines delivery obligations, noting that statutory rescission rights commence only upon the purchaser's receipt of all relevant supplements.